Gender-related differences in proliferative responses of vascular smooth muscle cells to endothelin-1

被引:22
作者
Antoniucci, D
Miller, VM
Sieck, GC
Fitzpatrick, LA
机构
[1] Mayo Clin & Mayo Fdn, Dept Internal Med, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Anesthesiol, Rochester, MN 55905 USA
[3] Mayo Clin & Mayo Fdn, Dept Surg, Rochester, MN 55905 USA
来源
ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH | 2001年 / 8卷 / 02期
关键词
cell culture; estradiol; vasoconstriction;
D O I
10.3109/10623320109165322
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Endothelin-1 is an endothelium-derived factor which alters tone and proliferation of vascular smooth muscle and has been implicated in the development of atherosclerosis. Estrogen modulates production of and contractile responses to endothelin-1. Since atherosclerosis is less in estrogen-replete women compared to men, experiments were designed to determine whether or not there were gender-associated differences in proliferative responses to endothelin-1 and effect of estrogen status on those responses. Proliferation of smooth muscle cells derived from coronary arteries of sexually mature, gondally intact male and female and oophorectomized female pigs was determined by thymidine incorporation in the absence and presence of endothelin-1 with and without 17 beta -estradiol. Endothelin-1 (10(-9) M to 10(-7) M) significantly inhibited proliferation only in coronary smooth muscle cells from intact female pigs. Addition of beta -estradiol inhibited proliferation of cells from intact females but there was not a synergistic effect with endothelin-1. Gender associated inhibition of smooth muscle proliferation by endothelin-1 may contribute, in part, to cardioprotection noted in estrogen-replete states.
引用
收藏
页码:137 / 145
页数:9
相关论文
共 54 条
[1]  
ALBERTS GF, 1994, J BIOL CHEM, V269, P10112
[2]  
Bacáková L, 1999, CELL BIOL INT, V23, P643
[3]   Gender differences in growth of vascular smooth muscle cells isolated from hypertensive and normotensive rats [J].
Bacáková, L ;
Kunes, J .
CLINICAL AND EXPERIMENTAL HYPERTENSION, 2000, 22 (01) :33-44
[4]   Endothelin receptors are modulated in association with endogenous fluctuations in estrogen [J].
Barber, DA ;
Sieck, GC ;
Fitzpatrick, LA ;
Miller, VM .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1996, 271 (05) :H1999-H2006
[5]   Gender differences in endothelium-dependent relaxations do not involve NO in porcine coronary arteries [J].
Barber, DA ;
Miller, VM .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 273 (05) :H2325-H2332
[6]   Hormone and nonhormone therapy for the maintenance of postmenopausal health: The need for randomized controlled trials of estrogen and raloxifene [J].
Barrett-Connor, E ;
Wenger, NK ;
Grady, D ;
Mosca, L ;
Collins, P ;
Kornitzer, M ;
Cox, DA ;
Moscarelli, E ;
Anderson, PW .
JOURNAL OF WOMENS HEALTH, 1998, 7 (07) :839-847
[7]   Coronary endothelial function is preserved with chronic endothelin receptor antagonism in experimental hypercholesterolemia in vitro [J].
Best, PJM ;
Lerman, LO ;
Romero, JC ;
Richardson, D ;
Holmes, DR ;
Lerman, A .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (11) :2769-2775
[8]   The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women [J].
Best, PJM ;
Berger, PB ;
Miller, VM ;
Lerman, A .
ANNALS OF INTERNAL MEDICINE, 1998, 128 (04) :285-288
[9]   Chronic endothelin receptor antagonism preserves coronary endothelial function in experimental hypercholesterolemia [J].
Best, PJM ;
McKenna, CJ ;
Hasdai, D ;
Holmes, DR ;
Lerman, A .
CIRCULATION, 1999, 99 (13) :1747-1752
[10]   GROWTH-FACTOR ACTIVITY OF ENDOTHELIN ON VASCULAR SMOOTH-MUSCLE [J].
BOBIK, A ;
GROOMS, A ;
MILLAR, JA ;
MITCHELL, A ;
GRINPUKEL, S .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 258 (03) :C408-C415